CVS, Barclays and Medicare
CVS Health Positioned For Medicare Margin Expansion And Market Share Gains, Says Barclays Analyst
Barclays upgraded CVS Health Inc (NYSE:CVS) on higher Pharmacy & Consumer Wellness (PCW) estimates as headwinds are offset by share gains, with further upside potential from CostVantage. Despite macroeconomic pressures impacting the retail pharmacy sector,
CVS Health upgraded at Barclays on Medicare prospects
CVS Health (CVS) stock gained as Barclays upgraded the company, citing a compelling path to margin recovery in its Medicare Advantage business. Read more here.
Why CVS Health stock could appreciate 35% from here
Discover why TD Cowen sees 35% upside in CVS Health stock, driven by Medicare Advantage improvements and bullish technical signals.
Why CVS Health Won’t Break Off Aetna From Its Medical Providers
Talk that CVS Health may break up its businesses would mean unraveling synergies already making the company a lot of money.
CVS Stock Rises on Upgrade. Why Barclays Sees a ‘Compelling’ Opportunity.
Analysts upgraded shares of the healthcare company to Overweight from Equal Weight and raised their price target to $82.
Barclays ups CVS Health to Buy on positive margin outlook; shares rise
Barclays upgraded CVS Health Corp (NYSE:CVS) shares to Overweight from Equal Weight, citing a promising outlook for the company's margin recovery. The firm also raised its price target for CVS shares to $82 from $63.
2 Medicare Advantage plans to be cut in 2025
Humana Has a Problem. CVS and UnitedHealth Could Pick Up the Pieces.
Stock in the healthcare provider Humana came under pressure again on Friday after the U.S. government released quality ...
Fierce Healthcare2h
Medicare Advantage star ratings 2025—Who are the winners and losers?
Analyses of 2025 Medicare Advantage star ratings continue to pour in and not all of it bodes well for the conventional ...
CVS is under pressure and considering a breakup. Here's why that could be risky.
CVS risks losing customers and revenue if it splits up its vertically integrated business segments, which includes health ...
Modern Healthcare1d
Oak Street Health expansion to continue amid CVS review
CVS is reportedly conducting a strategic review and weighing options for separating some of the company’s businesses.
Healthcare Dive6h
Medicare Advantage star ratings fall again in 2025
About 40% of MA plans with prescription drug coverage will earn four or more stars, a dip from 42% this year, according to data released by the CMS.
Yahoo13h
Copycat weight loss drugs, Amazon's pharmacies, and CVS vs. Lina Khan: Pharma news round up
Read More Allowing Medicare to cover popular weight loss drugs such as Wegovy and Zepbound could increase federal spending ...